SARS-CoV-2 NP IgG ELISA Kit [CE-IVD]

1. Pieri M, Ciotti M, Carlozzi N, Frassanito ML, Meloni A, Cistera A, Turchetti G, Niscola S, Labate G, Calugi G, Bernardini S. SARS-CoV-2 infection serology validation of different methods: usefulness of IgA in the early phase of infection. Clinica Chimica Acta. 2020 Dec 1; 511:28-32. 2. Patel EU, Bloch EM, Clarke W, Hsieh YH, Boon D, Eby Y, Fernandez RE, Baker OR, Keruly M, Kirby CS, Klock E. Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers. Journal of Clinical Microbiology. 2021 Jan 21; 59(2). 3. Bavaro DF, Laghetti P, Milano E, Brindicci G, Volpe A, Lagioia A, Saracino A, Monno L. Anti?spike S1 receptor?binding domain antibodies against SARS?CoV?2 persist several months after infection regardless of disease severity. Journal of Medical Virology. 2021 Feb 16.